0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Elizabeth M. Swisher, MD
JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2699

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2690
Includes: Supplemental Content

JAMA Oncology | 
Editorial |  ONLINE FIRST
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD
JAMA Oncol. Published online July 02, 2015. doi:10.1001/jamaoncol.2015.1926

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.
JAMA Oncol. Published online July 02, 2015. doi:10.1001/jamaoncol.2015.1796
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Yuexin Liu, PhD; Maya Yasukawa, MD; Kexin Chen, MD, PhD; et al.
JAMA Oncol. 2015;1(4):486-494. doi:10.1001/jamaoncol.2015.1432.
Includes: Supplemental Content

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Andrew S. McDaniel, MD, PhD; Jennifer N. Stall, MD; Daniel H. Hovelson, MS; et al.
JAMA Oncol. Published online June 18, 2015. doi:10.1001/jamaoncol.2015.1618
Includes: Supplemental Content

JAMA | 
Original Investigation | 
Timothy R. Rebbeck, PhD; Nandita Mitra, PhD; Fei Wan, MS; et al.
JAMA. 2015;313(13):1347-1361. doi:10.1001/jama.2014.5985.
Includes: CME, Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Chenjie Zeng, MPH; Wanqing Wen, MD, MPH; Alicia K. Morgans, MD; et al.
JAMA Oncol. 2015;1(1):88-96. doi:10.1001/jamaoncol.2014.161.
Includes: Supplemental Content

JAMA Surgery | 
Original Investigation | 
Alexandra Gangi, MD; Ilana Cass, MD; Daniel Paik, MD; et al.
JAMA Surg. 2014;149(12):1306-1313. doi:10.1001/jamasurg.2014.1081.

JAMA | 
Medical News & Perspectives | 
Kate O’Rourke
JAMA. 2014;312(3):218-219. doi:10.1001/jama.2014.7708.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Network Collections
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Usefulness of Multigene Testing Catching the Train That’s Left the Station
Elizabeth M. Swisher, MD
JAMA Oncology
Original Investigation  | 
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncology
Editorial  | 
Ovarian Cancer Survival and Chemotherapy Dosing, Body Mass Index, and Body Surface Area  Are We There Yet?
S. Percy Ivy, MD; Jan H. Beumer, PharmD, PhD
JAMA Oncology
Original Investigation  | 
Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index
Elisa V. Bandera, MD, PhD; Valerie S. Lee, MHS; Lorna Rodriguez-Rodriguez, MD, PhD; et al.